Scientist as strategist: expanding the role beyond the bench
Scientists who focus only on generating data risk missing their role in shaping strategy and driving innovation.
Scientist as strategist: expanding the role beyond the bench Read More »
Uncategorized
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
Lilly, J&J CEOs top pharma’s highest paid list—again Read More »
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue? Read More »
Artera gets FDA clearance for AI breast cancer risk prediction tool
The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
Artera gets FDA clearance for AI breast cancer risk prediction tool Read More »
Employers say they prefer rebate-free PBM models
More than 90% of employers agreed a rebate-free approach is easier to understand and would improve drug price transparency, according to the survey conducted for Evernorth, which operates a pharmacy benefit manager.
Employers say they prefer rebate-free PBM models Read More »
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
FDA chief Marty Makary resigns from agency, ending tumultuous tenure Read More »
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
FDA chief Marty Makary resigns from agency, ending tumultuous tenure Read More »
Optum Rx shifts to fee-based PBM model in bid to boost transparency
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
Optum Rx shifts to fee-based PBM model in bid to boost transparency Read More »
Bayesian Health gets FDA nod for AI sepsis detection tool
Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.
Bayesian Health gets FDA nod for AI sepsis detection tool Read More »
Una inteligencia artificial capaz de idear millones de moléculas nuevas
La búsqueda de nuevas moléculas es uno de los grandes retos de la química moderna. Desde el desarrollo de fármacos hasta la creación de materiales más sostenibles, todo se enfoca en encontrar combinaciones de átomos con propiedades útiles. &nb …
Una inteligencia artificial capaz de idear millones de moléculas nuevas Read More »